Abstract: |
Morphine administration can lead to a variety of side-effects, including myoclonus. In an animal model, high morphine doses given intrathecally elicit hindlimb myoclonic seizures which are not influenced by traditional opioid receptor antagonists, such as naloxone. Ketamine prevents this seizure-like activity in a dose-dependent manner. The response is stereoselective, with S-ketamine far more potent than R-ketamine. A competitive NMDA antagonist, NPC17742, also prevents the seizures, although less potently than ketamine. Dextromethorphan has limited activity in this model, while haloperidol and pentothal are without any effect. |
Keywords: |
controlled study; nonhuman; mouse; animals; mice; haloperidol; animal experiment; animal model; dose-response relationship, drug; animalia; mice, inbred strains; seizure; amino acids; morphine; myoclonus; analgesics, opioid; disease models, animal; epilepsy; stereoisomerism; naloxone; ketamine; thiopental; opioid receptor; receptors, n-methyl-d-aspartate; intraperitoneal drug administration; excitatory amino acid antagonists; hindlimb; mu receptor; subcutaneous drug administration; n methyl dextro aspartic acid receptor blocking agent; male; priority journal; article; dextromethorphan; intrathecal drug administration; 2 amino 4,5 (1,2 cyclohexyl) 7 phosphonoheptanoic acid; epilepsies, myoclonic
|